These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27821747)

  • 1. Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer.
    Xu GJ; Shah AA; Li MZ; Xu Q; Rosen A; Casciola-Rosen L; Elledge SJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7526-E7534. PubMed ID: 27821747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated Scleroderma.
    Shah AA; Xu G; Rosen A; Hummers LK; Wigley FM; Elledge SJ; Casciola-Rosen L
    Arthritis Rheumatol; 2017 Jun; 69(6):1306-1312. PubMed ID: 28217959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ANP32A antibodies in systemic sclerosis.
    Wallwork R; Casciola-Rosen L; Shah AA
    Ann Rheum Dis; 2022 Feb; 81(2):301-302. PubMed ID: 34697026
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective Effect Against Cancer of Antibodies to the Large Subunits of Both RNA Polymerases I and III in Scleroderma.
    Shah AA; Laiho M; Rosen A; Casciola-Rosen L
    Arthritis Rheumatol; 2019 Sep; 71(9):1571-1579. PubMed ID: 30888702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma.
    Shah AA; Hummers LK; Casciola-Rosen L; Visvanathan K; Rosen A; Wigley FM
    Arthritis Rheumatol; 2015 Apr; 67(4):1053-61. PubMed ID: 25605296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
    Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
    J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/arginine splicing factors during apoptosis.
    Overzet K; Gensler TJ; Kim SJ; Geiger ME; van Venrooij WJ; Pollard KM; Anderson P; Utz PJ
    Arthritis Rheum; 2000 Jun; 43(6):1327-36. PubMed ID: 10857791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoepitope mapping of the centrosome autoantigen PCM-1 using scleroderma sera with anticentrosome autoantibodies.
    Bao L; Zimmer WE; Balczon R
    Autoimmunity; 1995; 22(4):219-28. PubMed ID: 8781714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structure and function of autoantigens in systemic sclerosis.
    Lee B; Craft JE
    Int Rev Immunol; 1995; 12(2-4):129-44. PubMed ID: 7650417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the autoimmune disease scleroderma with an immunologic response to cancer.
    Joseph CG; Darrah E; Shah AA; Skora AD; Casciola-Rosen LA; Wigley FM; Boin F; Fava A; Thoburn C; Kinde I; Jiao Y; Papadopoulos N; Kinzler KW; Vogelstein B; Rosen A
    Science; 2014 Jan; 343(6167):152-7. PubMed ID: 24310608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and Dermatomyositis.
    Fiorentino DF; Casciola-Rosen L
    Clin Rev Allergy Immunol; 2022 Dec; 63(3):330-341. PubMed ID: 35593962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.
    Shah AA; Rosen A
    Curr Opin Rheumatol; 2011 Nov; 23(6):530-5. PubMed ID: 21825998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
    Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
    Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.
    Imai H; Chan EK; Kiyosawa K; Fu XD; Tan EM
    J Clin Invest; 1993 Nov; 92(5):2419-26. PubMed ID: 8227358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMMUNOEDITING IN AUTOIMMUNE RHEUMATIC DISEASES.
    Rosen A
    Trans Am Clin Climatol Assoc; 2022; 132():34-43. PubMed ID: 36196176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic autoantibodies in systemic sclerosis.
    Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
    Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease.
    Shah AA; Rosen A; Hummers LK; May BJ; Kaushiva A; Roden RBS; Armstrong DK; Wigley FM; Casciola-Rosen L; Visvanathan K
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):71-74. PubMed ID: 28628466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
    Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.